Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone furoate MDI dose-ranging study in children with persistent asthma
2008-007504-28Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of mometasone in persistent asthma (5 arms), sponsored by Merck & Co. Primary endpoint: Change in percent predicted FEV1 from baseline to Week 12. Started Dec 2011; status: completed.
02
Drugs
mometasone
03
Conditions
persistent asthma
Beyond the preview
Go deeper on 2008-007504-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007504-28.